Profile | GDS5420 / 206090_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 183.88 | 51 |
GSM1296119 | B_lesional_pre-dose | 309.45 | 60 |
GSM1296076 | C_lesional_pre-dose | 291.29 | 60 |
GSM1296092 | D_lesional_pre-dose | 275.02 | 59 |
GSM1296103 | E_lesional_pre-dose | 202.01 | 53 |
GSM1296078 | F_lesional_pre-dose | 198.75 | 54 |
GSM1296107 | G_lesional_pre-dose | 224.25 | 54 |
GSM1296109 | H_lesional_pre-dose | 139.64 | 45 |
GSM1296080 | I_lesional_pre-dose | 129.11 | 47 |
GSM1296090 | J_lesional_pre-dose | 328.33 | 61 |
GSM1296074 | K_lesional_pre-dose | 251.21 | 58 |
GSM1296111 | L_lesional_pre-dose | 364.18 | 62 |
GSM1296099 | M_lesional_pre-dose | 243.49 | 55 |
GSM1296086 | O_lesional_pre-dose | 255.02 | 58 |
GSM1296117 | P_lesional_pre-dose | 284.97 | 58 |
GSM1296113 | Q_lesional_pre-dose | 305.34 | 58 |
GSM1296096 | R_lesional_pre-dose | 220.97 | 54 |
GSM1296105 | S_lesional_pre-dose | 211.29 | 52 |
GSM1296098 | T_lesional_pre-dose | 168.38 | 49 |
GSM1296101 | U_lesional_pre-dose | 165.38 | 49 |
GSM1296121 | V_lesional_pre-dose | 274.43 | 57 |
GSM1296088 | W_lesional_pre-dose | 217.27 | 54 |
GSM1296082 | X_lesional_pre-dose | 207.84 | 55 |
GSM1296115 | Y_lesional_pre-dose | 247.97 | 55 |
GSM1296084 | Z_lesional_pre-dose | 236.71 | 55 |
GSM1296072 | B_lesional_day8 | 413.05 | 64 |
GSM1296069 | L_lesional_day8 | 415.35 | 64 |
GSM1296071 | P_lesional_day8 | 430.69 | 64 |
GSM1296070 | Y_lesional_day8 | 304.67 | 58 |
GSM1296073 | V_lesional_day8 | 245.27 | 56 |
GSM1296034 | A_lesional_day15 | 116.51 | 43 |
GSM1296041 | G_lesional_day15 | 244.99 | 55 |
GSM1296035 | R_lesional_day15 | 244.38 | 56 |
GSM1296038 | U_lesional_day15 | 242.07 | 55 |
GSM1296047 | B_lesional_day15 | 395.89 | 63 |
GSM1296039 | E_lesional_day15 | 268.87 | 58 |
GSM1296042 | H_lesional_day15 | 298.32 | 58 |
GSM1296043 | L_lesional_day15 | 366.9 | 62 |
GSM1296037 | M_lesional_day15 | 237.26 | 55 |
GSM1296046 | P_lesional_day15 | 367.54 | 62 |
GSM1296044 | Q_lesional_day15 | 223.69 | 52 |
GSM1296045 | Y_lesional_day15 | 397.47 | 63 |
GSM1296025 | C_lesional_day15 | 245.44 | 56 |
GSM1296033 | D_lesional_day15 | 248.69 | 56 |
GSM1296027 | I_lesional_day15 | 314.23 | 61 |
GSM1296032 | J_lesional_day15 | 354.28 | 61 |
GSM1296024 | K_lesional_day15 | 253.06 | 57 |
GSM1296031 | W_lesional_day15 | 299.38 | 58 |
GSM1296028 | X_lesional_day15 | 316.16 | 60 |
GSM1296029 | Z_lesional_day15 | 359.88 | 62 |
GSM1296026 | F_lesional_day15 | 201.78 | 53 |
GSM1296030 | O_lesional_day15 | 243.8 | 57 |
GSM1296040 | S_lesional_day15 | 171.25 | 49 |
GSM1296036 | T_lesional_day15 | 209.19 | 52 |
GSM1296048 | V_lesional_day15 | 322.58 | 60 |
GSM1296059 | A_lesional_day43 | 164.14 | 50 |
GSM1296066 | G_lesional_day43 | 296.36 | 58 |
GSM1296060 | R_lesional_day43 | 330.86 | 60 |
GSM1296063 | U_lesional_day43 | 376.49 | 63 |
GSM1296064 | E_lesional_day43 | 200.88 | 53 |
GSM1296067 | H_lesional_day43 | 385.47 | 62 |
GSM1296062 | M_lesional_day43 | 169.47 | 49 |
GSM1296068 | Q_lesional_day43 | 284.76 | 56 |
GSM1296050 | C_lesional_day43 | 376.97 | 63 |
GSM1296057 | D_lesional_day43 | 374.57 | 62 |
GSM1296052 | I_lesional_day43 | 415.02 | 65 |
GSM1296054 | J_lesional_day43 | 383.96 | 63 |
GSM1296049 | K_lesional_day43 | 366.76 | 63 |
GSM1296055 | W_lesional_day43 | 361.3 | 62 |
GSM1296053 | X_lesional_day43 | 227.12 | 54 |
GSM1296058 | Z_lesional_day43 | 253.19 | 56 |
GSM1296051 | F_lesional_day43 | 270.77 | 58 |
GSM1296056 | O_lesional_day43 | 286.81 | 59 |
GSM1296065 | S_lesional_day43 | 238.38 | 55 |
GSM1296061 | T_lesional_day43 | 184.65 | 51 |
GSM1296095 | A_non-lesional_pre-dose | 229.75 | 55 |
GSM1296120 | B_non-lesional_pre-dose | 332.96 | 60 |
GSM1296077 | C_non-lesional_pre-dose | 275.97 | 58 |
GSM1296093 | D_non-lesional_pre-dose | 295.38 | 58 |
GSM1296104 | E_non-lesional_pre-dose | 221.98 | 54 |
GSM1296079 | F_non-lesional_pre-dose | 246.08 | 56 |
GSM1296108 | G_non-lesional_pre-dose | 275.28 | 57 |
GSM1296110 | H_non-lesional_pre-dose | 245.73 | 54 |
GSM1296081 | I_non-lesional_pre-dose | 197.49 | 53 |
GSM1296091 | J_non-lesional_pre-dose | 220.82 | 55 |
GSM1296075 | K_non-lesional_pre-dose | 222.83 | 55 |
GSM1296112 | L_non-lesional_pre-dose | 393.59 | 63 |
GSM1296100 | M_non-lesional_pre-dose | 210.09 | 52 |
GSM1296087 | O_non-lesional_pre-dose | 286.56 | 60 |
GSM1296118 | P_non-lesional_pre-dose | 335.25 | 60 |
GSM1296114 | Q_non-lesional_pre-dose | 273.32 | 56 |
GSM1296097 | R_non-lesional_pre-dose | 338.88 | 61 |
GSM1296106 | S_non-lesional_pre-dose | 221.51 | 53 |
GSM1296102 | U_non-lesional_pre-dose | 240.21 | 54 |
GSM1296122 | V_non-lesional_pre-dose | 261.94 | 56 |
GSM1296089 | W_non-lesional_pre-dose | 240.07 | 55 |
GSM1296083 | X_non-lesional_pre-dose | 238.17 | 55 |
GSM1296116 | Y_non-lesional_pre-dose | 279.63 | 56 |
GSM1296085 | Z_non-lesional_pre-dose | 214.32 | 54 |